about
Preliminary data on the relationship between circulating levels of Sirtuin 4, anthropometric and metabolic parameters in obese subjects according to growth hormone/insulin-like growth factor-1 status.Bisphenol A in polycystic ovary syndrome and its association with liver-spleen axis.Vitamin D and cancer.Nutrition and psoriasis: is there any association between the severity of the disease and adherence to the Mediterranean diet?Liver-spleen axis, insulin-like growth factor-(IGF)-I axis and fat mass in overweight/obese females.Evaluation of the retinal nerve fibre layer and ganglion cell complex thickness in pituitary macroadenomas without optic chiasmal compression.Serum 25-Hydroxyvitamin D Levels, phosphoprotein enriched in diabetes gene product (PED/PEA-15) and leptin-to-adiponectin ratio in women with PCOSSelf-Assessment of Adherence to Medication: A Case Study in Campania Region Community-Dwelling Population.Nutrition: a key environmental dietary factor in clinical severity and cardio-metabolic risk in psoriatic male patients evaluated by 7-day food-frequency questionnaire.Bioelectrical phase angle and psoriasis: a novel association with psoriasis severity, quality of life and metabolic syndrome.Hepatic steatosis in overweight/obese females: new screening method for those at riskVitamin-D & prediabetes: a promising ménage in the Indian ScenarioEndocrine changes (beyond diabetes) after bariatric surgery in adult life.The complex relationship between obesity and the somatropic axis: the long and winding road.Osteoporosis across chronic liver disease.Growth hormone treatment of adolescents with growth hormone deficiency (GHD) during the transition period: results of a survey among adult and paediatric endocrinologists from Italy. Endorsed by SIEDP/ISPED, AME, SIE, SIMA.Nutrition, inflammation and liver-spleen axis.Influence of nutrition on somatotropic axis: Milk consumption in adult individuals with moderate-severe obesity.Cardiovascular risk in adult hypopituitaric patients with growth hormone deficiency: is there a role for vitamin D?Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin-secreting and clinically non-functioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I-methoxybenzamide.A Community-Based, Technology-Supported Health Service for Detecting and Preventing Frailty among Older Adults: A Participatory Design Development Process.The growth hormone-insulin-like growth factor axis in glycogen storage disease type 1: evidence of different growth patterns and insulin-like growth factor levels in patients with glycogen storage disease type 1a and 1b.The GH-IGF system in amyotrophic lateral sclerosis: correlations between pituitary GH secretion capacity, insulin-like growth factors and clinical features.Prevalence of the metabolic syndrome in moderately-severely obese subjects with and without growth hormone deficiency.A reappraisal of diagnosing GH deficiency in adults: role of gender, age, waist circumference, and body mass index.Osteoporosis drugs in real-world clinical practice: an analysis of persistence.Increased arterial intima-media thickness by B-M mode echodoppler ultrasonography in acromegaly.Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency.Usefulness of CV 205-502 in a case of allergy to ergot-derived drugs.Severe impairment of bone mass and turnover in Cushing's disease: comparison between childhood-onset and adulthood-onset disease.The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study.Cardiovascular consequences of early-onset growth hormone excess.Spine abnormalities and damage in patients cured from Cushing's disease.The cardiovascular risk of GH-deficient adolescents.Effect of growth hormone (GH) and/or testosterone replacement on the prostate in GH-deficient adult patients.Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study.Central diabetes insipidus and autoimmunity: relationship between the occurrence of antibodies to arginine vasopressin-secreting cells and clinical, immunological, and radiological features in a large cohort of patients with central diabetes insipidNephrolithiasis in Cushing's disease: prevalence, etiopathogenesis, and modification after disease cure.Occurrence of GH deficiency in adult patients who underwent neurosurgery in the hypothalamus-pituitary area for non-functioning tumour masses.Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission.
P50
Q30873929-77BFC237-1E68-4158-9DA7-66D7E4761BC2Q34032834-05833A3F-02B2-4131-9A5A-1169534A38EFQ34278228-B9AAEC6A-76CC-4A51-8111-E9AE5CCD5EBBQ35047630-2200118F-80FC-4853-9933-C61855FFC6BEQ35225973-A8794C84-148E-4871-A753-21C8D0D4CCECQ35748977-FB524B25-8C26-40BE-9D82-5E8F87FB5D42Q35802456-6F51D3FD-4BBD-44A3-ABA4-8C65711DB190Q35969028-5053BBF1-A8EA-4BD7-91E1-A7869C5D9CECQ36063026-7514432A-9441-46FF-92C4-04BA19E86746Q36890664-D555D444-2BE0-4C7E-963B-6BC2B1D5B669Q37461182-E5AC7D05-EE65-4002-BB48-B82FEBE965FCQ37690806-F1680F65-94CF-4D33-8AFC-C7A87F336ED6Q38085447-BB517D00-D40F-4B2D-9336-D6BF6438C818Q38260202-CD9D7C9E-12D4-4CD2-8FEC-C6EB0ED22EC8Q38723451-A8450D2D-30DB-44ED-8FC7-798941544544Q39104763-61640199-56ED-4112-9183-5C2ED7A31A1DQ40086170-3B69E945-4AF7-45DE-A876-0D6B24111CC1Q40144424-37137F88-12C3-47BE-AFBA-204053AB6C62Q41173285-FA0B4C2F-3357-4219-AD4E-A50DD76D43D9Q42486526-284A0F41-8AA3-4385-994B-752F868AB830Q42595431-4E80B482-FB22-4137-92BB-4143D7543BAFQ43214891-BC28BC6C-EFF8-4F4A-80EC-73B10BB42781Q43225312-27089DED-EA8F-4049-A9B4-A477600ACCC8Q43268918-3A960F0A-8243-4F6E-90F7-F4ACB2FF2ABEQ43272847-10C2E7B5-9AF6-4359-8AFB-00329787BD3FQ43444680-981C400D-20EF-4AA6-B84C-ED207CC5EF74Q43586019-06CD549A-BC6B-4041-B679-B77B27517D7BQ43601772-A5F47AFD-2489-4BF8-A464-9FC7E0EA46D4Q43754170-AFBB8773-EEB6-419E-B7E1-625AF37D12C5Q43902744-FCEE8C2E-EAF5-4F62-810B-5081C05975CDQ43913838-1CA9E97A-6D68-4DEC-BA28-EFFAAF296A4DQ44055126-014C4AF2-3D1B-4EFC-96EF-2E919434E27BQ44077760-FD1A9F05-CF9A-4DB4-9C2B-48DCA5809EBDQ44089032-C1F6EFD0-D874-487C-B2F6-4EB839FCDDD1Q44273247-EC5DF126-954F-48B1-92E6-D58AC5A44031Q44331759-5522E565-1AC7-449E-87EC-479F732D987AQ44392879-DB17CDCD-51C2-40CD-A1B7-30743A43197CQ44427453-4A288623-EECE-42AA-86E3-1D1A98481C44Q44433002-22A1A0A1-877F-4139-8DC7-DD5108B5AE5CQ44467027-6BE38064-3789-42A6-AD60-C41C70284577
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Carolina Di Somma
@ast
Carolina Di Somma
@en
Carolina Di Somma
@es
Carolina Di Somma
@nl
Carolina Di Somma
@sl
type
label
Carolina Di Somma
@ast
Carolina Di Somma
@en
Carolina Di Somma
@es
Carolina Di Somma
@nl
Carolina Di Somma
@sl
prefLabel
Carolina Di Somma
@ast
Carolina Di Somma
@en
Carolina Di Somma
@es
Carolina Di Somma
@nl
Carolina Di Somma
@sl
P1053
K-7772-2016
P106
P1153
7005347231
P21
P31
P496
0000-0002-5724-1951